These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28487213)

  • 1. Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014.
    Tan KR; Henderson SJ; Williamson J; Ferguson RW; Wilkinson TM; Jung P; Arguin PM
    Travel Med Infect Dis; 2017; 17():50-55. PubMed ID: 28487213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013.
    Landman KZ; Tan KR; Arguin PM;
    MMWR Morb Mortal Wkly Rep; 2014 Jun; 63(23):516-7. PubMed ID: 24918487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to malaria prophylaxis among Peace Corps Volunteers in the Africa region, 2013.
    Landman KZ; Tan KR; Arguin PM
    Travel Med Infect Dis; 2015; 13(1):61-8. PubMed ID: 25534297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deployment and Travel Medicine Knowledge, Attitudes, Practices, and Outcomes Study (KAPOS): Malaria Chemoprophylaxis Prescription Patterns in the Military Health System.
    Hickey PW; Mitra I; Fraser J; Brett-Major D; Riddle MS; Tribble DR
    Am J Trop Med Hyg; 2020 Jul; 103(1):334-343. PubMed ID: 32342855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic use of antimalarials during pregnancy.
    Irvine MH; Einarson A; Bozzo P
    Can Fam Physician; 2011 Nov; 57(11):1279-81. PubMed ID: 22084457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malaria--chemoprophylaxis 2001].
    Hatz FR; Beck B; Blum J; Funk M; Furrer H; Genton B; Holzer B; Loutan L; Markwalder K; Raeber PA; Schlagenhauf P; Siegl G; Steffen R; Stürchler D; Wyss R
    Ther Umsch; 2001 Jun; 58(6):347-51. PubMed ID: 11441694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
    Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y
    J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.
    Lachish T; Bar-Meir M; Eisenberg N; Schwartz E
    J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadequate chemoprophylaxis and the risk of malaria.
    Massey P; Durrheim DN; Speare R
    Aust Fam Physician; 2007 Dec; 36(12):1058-60. PubMed ID: 18075636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of chemoprophylaxis on the timing of onset of falciparum malaria.
    Reyburn H; Behrens RH; Warhurst D; Bradley D
    Trop Med Int Health; 1998 Apr; 3(4):281-5. PubMed ID: 9623928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair concentrations of anti-malarials in returned travellers-the HAIR study: Proof of principle analysis.
    Steiner R; Kaulich A; Müller D; Schlagenhauf P
    Travel Med Infect Dis; 2023; 54():102590. PubMed ID: 37209974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported adverse events associated with antimalarial chemoprophylaxis in peace corps volunteers.
    Korhonen C; Peterson K; Bruder C; Jung P
    Am J Prev Med; 2007 Sep; 33(3):194-9. PubMed ID: 17826578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in antimalarial prescriptions in Australia 2002 to 2005.
    Leggat PA
    J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-malarial chemoprophylaxis following evacuation from Afghanistan.
    Keene DD; Tong JL; Roughton S; Fadden SJ
    J R Army Med Corps; 2012 Mar; 158(1):38-40; discussion 40. PubMed ID: 22545372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.
    Carme B; Peguet C; Nevez G
    Trop Med Int Health; 1997 Oct; 2(10):953-6. PubMed ID: 9357484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-tolerated chemoprophylaxis uniformly prevented Swedish soldiers from Plasmodium falciparum malaria in Liberia, 2004-2006.
    Andersson H; Askling HH; Falck B; Rombo L
    Mil Med; 2008 Dec; 173(12):1194-8. PubMed ID: 19149338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.